COMMUNIQUÉS West-GlobeNewswire

Galectin Therapeutics Announces Extension of $10 Million Line Credit
20/12/2018
NORCROSS, Ga., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that its $10 million unsecured line of [...]
Assure Holdings Appoints Dr. Christopher Rumana to its Board of Directors
20/12/2018
DENVER, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCPK: ARHH), a provider of intraoperative neuromonitoring services, has appointed Dr. Christopher Rumana to [...]
Adverum to Present at the 37th Annual J.P. Morgan Healthcare Conference
20/12/2018
MENLO PARK, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today announced [...]
Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
20/12/2018
-- Golodirsen has been studied for the treatment of exon 53 amenable patients, approximately eight percent of patients with Duchenne -- -- Submission represents ongoing advancement of the company’s proprietary PMO RNA- [...]
Director/PDMR Shareholding
20/12/2018
Director/PDMR Shareholding 20 December, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]
Acasti Pharma Achieves Planned Enrollment Targets for TRILOGY Phase 3 Trials of CaPre® in Patients with Severe Hypertriglyceridemia
20/12/2018
LAVAL, Québec, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Synthorx Appoints Andrew Powell, J.D., to its Board of Directors
20/12/2018
Pratik Shah., Ph.D., Appointed Chairman of the Board SAN DIEGO, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform [...]
NORTHBUD Amends Licence Application to Add 500K SQ. FT. of Outdoor Cultivation Area and Provides a Corporate Update
20/12/2018
TORONTO, Dec. 20, 2018 (GLOBE NEWSWIRE) -- North Bud Farms Inc. (CSE: NBUD) ("NORTHBUD" or the "Company") announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area and provides [...]
VBI Vaccines Announces Phase 2 Clinical Study Design of its Prophylactic CMV Vaccine Candidate
20/12/2018
CAMBRIDGE, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today [...]
CytomX Therapeutics Announces Changes to its Board of Directors
20/12/2018
- President and CEO Sean McCarthy, D. Phil., Appointed to Additional Role of Chairman - - Hoyoung Huh, M.D., Ph.D. Retiring from Board - - James R. Meyers, Former EVP at Gilead Sciences, Appointed to Board - SOUTH SAN [...]
Replimune to Present at the 37th Annual J.P.Morgan Healthcare Conference
20/12/2018
WOBURN, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immunotherapies derived from its Immulytic™ platform, today announced that Robert Coffin [...]
Cue Biopharma and LG Chem Life Sciences Announce WT1 as the Next Immuno-STAT™ Target in Oncology
20/12/2018
WT1 is a Well-Characterized Oncofetal Antigen, Expressed in Solid Tumors and Hematologic Malignancies CAMBRIDGE, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma ™, Inc., (NASDAQ: CUE) an innovative immunotherapy [...]
Retrophin Completes Enrollment of Pivotal Phase 3 FORT Study of Fosmetpantotenate in PKAN
20/12/2018
Top-line data anticipated in the third quarter of 2019 SAN DIEGO, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced completion of patient enrollment in the pivotal Phase 3 FORT Study, [...]
Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
20/12/2018
- 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic - Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Pascal [...]
Diamond CBD and Marine Toys For Tots Foundation Bring Holiday Cheer to Needy Kids
20/12/2018
Industry leader in hemp extraction donates hundreds of toys following another successful year FORT LAUDERDALE, Fla., Dec. 20, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE Diamond CBD Inc. , wholly owned subsidiary of [...]
NanoVibronix Signs Major Distributor in India for UroShield®
20/12/2018
ELMSFORD, N.Y., Dec. 20, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today [...]
ALK – Financial calendar for the 2019 financial year
20/12/2018
2019 financial calendar for ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): Silent period 10 January 2019 Annual report 2018 7 February 2019 Annual General Meeting to be held 13 March 2019 at ALK 4.00 p.m. Bøge Allé 1 [...]
Leading National Specialty Pharmacy Selects ScriptMed® Cloud for Advanced Pharmacy Capabilities
20/12/2018
Top 10 Specialty Pharmacy to Implement the Inovalon ONE® Platform Cloud-Based Capabilities to Drive Increased Efficiencies and Outcomes BOWIE, Md., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading [...]
Arch Therapeutics to Provide Corporate Update at the 11th Annual Biotech Showcase™ 2019 Conference on January 8th, 2019
20/12/2018
FRAMINGHAM, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]

Pages